No Photo Available

Last Update

2017-03-09T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Gary Woodnutt?

Dr. Gary Woodnutt

Chief Scientific Officer

Transposagen Biopharmaceuticals Inc

HQ Phone: (859) 428-8561

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Transposagen Biopharmaceuticals Inc

535 West Second St. Suite 10

Lexington, Kentucky 40508

United States

Company Description

Transposagen Biopharmaceuticals, Inc., a Lexington, KY based company, is the worldwide leader in the creation of unique genetically modified rat models. The company's signature product, TKO(TM) Knockout Rat Models, mimic human diseases and are used for dr ... more

Find other employees at this company (20)

Background Information

Employment History

Position, Pharmaceutical Industry

Glaxo SmithKline Pharmaceuticals

Position, Pharmaceutical Industry

GlaxoSmithKline plc

Head of Biology

CovX

Cso

Lpath , Inc.

Vice President, Open Innovation

Pfizer Inc

Head of Pharmaceutical Research and Development

Verenium Corporation

Affiliations

Speakers and Advisor
IBC USA Conferences , Inc.

Parent Member
Del Mar Union School District

Education

B.S. degree

Biochemistry and Physiology

University of Leeds

Ph.D

Ph.D degree

Biochemistry and Physiology

University of Reading

Web References (30 Total References)


Our People | Transposagen Biopharmaceuticals

www.transposagenbio.com [cached]

Dr. Gary Woodnutt

Chief Scientific Officer
Dr. Gary Woodnutt is the Chief Scientific Officer for Transposagen bringing to the role extensive experience in drug discovery and pharmaceutical research. Prior to joining Transposagen, Dr. Woodnutt served as CSO of Lpath where he led all Discovery and Development activities concerning the exploitation of monoclonal antibodies to bioactive lipids. Dr. Woodnutt served as the Vice President, Open Innovation at Pfizer/CovX from 2012 to 2013, but his primary role at CovX, from 2006 to 2012, was as Vice President of Biology Research. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.


Gary Woodnutt ...

phx.corporate-ir.net [cached]

Gary Woodnutt Ph.D.

Senior Vice President and Chief Scientific Officer
Dr. Woodnutt joined Lpath in April 2013. Prior to joining Lpath, Dr. Woodnutt served as the Vice President, Open Innovation at CovX, a division of Pfizer acquired in 2007, from 2012 to 2013, and as Vice President of Biology Research from 2006 to 2012. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.


Gary Woodnutt ...

phx.corporate-ir.net [cached]

Gary Woodnutt Ph.D.

...
Gary Woodnutt Ph.D.
Senior Vice President and Chief Scientific Officer
Dr. Woodnutt joined Lpath in April 2013. Prior to joining Lpath, Dr. Woodnutt served as the Vice President, Open Innovation at CovX, a division of Pfizer acquired in 2007, from 2012 to 2013, and as Vice President of Biology Research from 2006 to 2012. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.


Gary Woodnutt, Ph.D. ...

phx.corporate-ir.net [cached]

Gary Woodnutt, Ph.D.


Gary Woodnutt, ...

www.sec.gov [cached]

Gary Woodnutt, Ph.D.

...
Gary Woodnutt Ph.D.
Senior Vice President and Chief Scientific Officer
Dr. Woodnutt joined Lpath in April 2013. Prior to joining Lpath, Dr. Woodnutt served as the Vice President, Open Innovation at CovX, a division of Pfizer acquired in 2007, from 2012 to 2013, and as Vice President of Biology Research from 2006 to 2012. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.

Similar Profiles

Other People with this Name

Other people with the name Woodnutt

Emily Woodnutt
Eveline Day School

Daniel Woodnutt
ACCURO

Samantha Woodnutt
Icon Moving Services LTD

Patricia Woodnutt
Callaghan Innovation

Stephen Woodnutt
Delmatic

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory